Dynamk Capital

CellFE Inc. is a biotechnology company based in San Carlos, California, established in 2017. It specializes in the development of a microfluidics-based device designed to deliver gene-editing molecules into human cells. This innovative platform enhances the manufacturing and development of cell therapies by utilizing rapid cell compression techniques that facilitate the uptake of therapeutic molecules from surrounding fluids. By enabling the transport of hard-to-deliver molecules, CellFE aims to improve the effectiveness of treatments for various disorders, supporting medical researchers in their efforts to advance patient care and outcomes.

Lucid Scientific, Inc. is a biotechnology tools company based in Atlanta, Georgia, specializing in the development of real-time cellular activity monitors for drug discovery and biological research. The company focuses on providing innovative systems that enable researchers in academic institutions and pharmaceutical companies to conduct continuous and non-invasive analysis of cellular behavior. Its flagship technology, RESIPHER, utilizes proprietary high-resolution optical oxygen sensors to measure oxygen consumption in standard multi-well plates. This tool streams real-time data to a user-friendly web application, allowing researchers to gain valuable insights into the cellular environment directly from the incubator, thereby enhancing the efficiency of cell culture experiments.

Vernal Biosciences is an mRNA manufacturing company that specializes in providing high-purity mRNA for research and clinical applications. The company leverages advanced processing and analytical methods to streamline the manufacturing process, significantly reducing the time and uncertainty typically associated with developing advanced therapeutics. Vernal Biosciences offers its services on a transactional basis, focusing on mRNA and lipid nanoparticle-mRNA (LNP-mRNA) production for use in various research contexts involving cells, animals, and humans. This approach enables research professionals to access on-demand, high-purity mRNA, supporting efficient drug discovery and development while minimizing the need for substantial investments in specialized teams and facilities.

Vernal Biosciences is an mRNA manufacturing company that specializes in providing high-purity mRNA for research and clinical applications. The company leverages advanced processing and analytical methods to streamline the manufacturing process, significantly reducing the time and uncertainty typically associated with developing advanced therapeutics. Vernal Biosciences offers its services on a transactional basis, focusing on mRNA and lipid nanoparticle-mRNA (LNP-mRNA) production for use in various research contexts involving cells, animals, and humans. This approach enables research professionals to access on-demand, high-purity mRNA, supporting efficient drug discovery and development while minimizing the need for substantial investments in specialized teams and facilities.

Bionter is a company focused on transforming analytical testing to enhance public health. It develops advanced analytical testing devices that provide critical particle testing services essential for ensuring patient safety. Bionter's sub-visible particle testing is a mandatory requirement for any parenteral preparation and is utilized in various applications, including stability testing, drug formulation, process development, and in-process control during manufacturing. Through innovative combination light obscuration technology and smart automation, Bionter enables its clients to improve the quality and safety of their products.

Curi Bio is a biotechnology company dedicated to enhancing drug discovery and development through innovative technologies that leverage human stem cells, systems biology, and data analytics. The company aims to streamline the identification and development of new medicines by providing advanced biosystem platforms that integrate human cells and data. Curi Bio's technology offers a range of products designed for cell and tissue engineering, drug discovery, disease modeling, and fundamental cell biology research. By enabling in vivo maturation and alignment of various cell types, the company allows drug developers to conduct more accurate safety and efficacy tests on new drug candidates, ultimately fostering the advancement of next-generation human medicines.

Virica Biotech is a biotechnology company focused on enhancing the development and production of viral vector therapeutic products to improve human health. The company has developed a proprietary Viral Sensitizer technology, which encompasses a library of over one hundred small molecules. These viral sensitizers are designed to safely bypass the natural immunological defenses present in both humans and animals, thereby facilitating more effective viral medicines. By employing a throughput screening process, Virica identifies these molecules to address unmet needs in the production processes of viral medicine producers, ultimately enabling them to enhance their offerings affordably and efficiently.

Envisagenics, Inc. is a bioinformatics company founded in 2013 and headquartered in Huntington, New York. The company specializes in RNA therapeutics and aims to simplify complex biomedical data to expedite the development of innovative therapeutic solutions. Envisagenics leverages its advanced analytics platform, SpliceCore, which utilizes artificial intelligence and machine learning to analyze RNA sequencing data. This cloud-based platform enables researchers to identify splicing errors linked to various diseases, including genetic disorders and cancers, and to discover potential drug targets and biomarkers. By streamlining the drug discovery process through computational simulations, Envisagenics significantly reduces the time, cost, and risks associated with drug development, thereby facilitating partnerships with biopharmaceutical companies to advance RNA-based therapies.

Xcell Biosciences, Inc. is a San Francisco-based life science company founded in 2012, specializing in innovative technologies for cancer research and immunotherapy. The company has developed proprietary systems that capture, grow, and analyze cancer cells directly from patient blood samples, allowing for precise control over primary cell phenotype and function. This technology enhances the development and production of cell therapies, providing scientists with advanced tools for cell maintenance, expansion, and optimization. By supporting various primary cell types, including immune, stem, and tumor cells, Xcell Biosciences aims to improve predictive therapy development and clinical outcomes for patients undergoing immunotherapy.

Vectron Biosolutions AS is a biotechnology company based in Trondheim, Norway, founded in 2008. It specializes in the development and marketing of vector technologies for the biotechnology and life science sectors. The company offers a range of products, including bacterial cloning vectors and expression vectors designed for recombinant protein production in bacteria. Vectron also provides customized vectors tailored for specific applications and produces recombinant proteins. In addition to its product offerings, the company delivers services in protein production, vector design, and molecular engineering, aimed at supporting clients in their life science research endeavors. Vectron's innovative technology employs an inducible promoter to enhance bacterial strains, resulting in improved yield and solubility of therapeutic proteins, thereby facilitating advancements in the field.

Alpenglow Biosciences specializes in advanced 3D pathology solutions. The company offers an end-to-end platform that includes a high-throughput light-sheet microscope for nondestructive imaging of large tissues at sub-cellular resolution. This technology is complemented by proprietary sample preparation methods, cloud-based data processing, and visualization tools enhanced with artificial intelligence algorithms. These innovations aim to accelerate drug development and enhance clinical diagnostics in the healthcare industry.

Curi Bio is a biotechnology company dedicated to enhancing drug discovery and development through innovative technologies that leverage human stem cells, systems biology, and data analytics. The company aims to streamline the identification and development of new medicines by providing advanced biosystem platforms that integrate human cells and data. Curi Bio's technology offers a range of products designed for cell and tissue engineering, drug discovery, disease modeling, and fundamental cell biology research. By enabling in vivo maturation and alignment of various cell types, the company allows drug developers to conduct more accurate safety and efficacy tests on new drug candidates, ultimately fostering the advancement of next-generation human medicines.

Lucid Scientific, Inc. is a biotechnology tools company based in Atlanta, Georgia, specializing in the development of real-time cellular activity monitors for drug discovery and biological research. The company focuses on providing innovative systems that enable researchers in academic institutions and pharmaceutical companies to conduct continuous and non-invasive analysis of cellular behavior. Its flagship technology, RESIPHER, utilizes proprietary high-resolution optical oxygen sensors to measure oxygen consumption in standard multi-well plates. This tool streams real-time data to a user-friendly web application, allowing researchers to gain valuable insights into the cellular environment directly from the incubator, thereby enhancing the efficiency of cell culture experiments.

CellFE Inc. is a biotechnology company based in San Carlos, California, established in 2017. It specializes in the development of a microfluidics-based device designed to deliver gene-editing molecules into human cells. This innovative platform enhances the manufacturing and development of cell therapies by utilizing rapid cell compression techniques that facilitate the uptake of therapeutic molecules from surrounding fluids. By enabling the transport of hard-to-deliver molecules, CellFE aims to improve the effectiveness of treatments for various disorders, supporting medical researchers in their efforts to advance patient care and outcomes.

RoosterBio, Inc. is a biotechnology company specializing in the development of mesenchymal stem cells (MSCs) for the regenerative medicine sector. Founded in 2012 and headquartered in Frederick, Maryland, RoosterBio provides human bone marrow and adipose-derived MSCs tailored for tissue engineers and cell therapists. The company focuses on streamlining the research process in stem cell commercialization, enabling researchers to conduct high-impact studies more efficiently. RoosterBio's products are designed to assist in the regeneration of tissues and organs while also addressing immune-related diseases. The company has established strategic alliances with organizations like Pall Corporation and Tissue Regeneration Therapeutics Inc.

RoosterBio, Inc. is a biotechnology company specializing in the development of mesenchymal stem cells (MSCs) for the regenerative medicine sector. Founded in 2012 and headquartered in Frederick, Maryland, RoosterBio provides human bone marrow and adipose-derived MSCs tailored for tissue engineers and cell therapists. The company focuses on streamlining the research process in stem cell commercialization, enabling researchers to conduct high-impact studies more efficiently. RoosterBio's products are designed to assist in the regeneration of tissues and organs while also addressing immune-related diseases. The company has established strategic alliances with organizations like Pall Corporation and Tissue Regeneration Therapeutics Inc.

FloDesign Sonics is a company that specializes in innovative acoustic technology aimed at transforming the separations and filtration sectors. The firm utilizes 3D non-linear acoustic standing waves to capture, separate, and purify mixtures without the need for physical membranes, chemicals, or centrifugation. This groundbreaking approach has broad applications across various industries, including life sciences, oil and gas, food and beverage, and industrial processing. The primary focus of FloDesign Sonics is in bioprocess separations, where it applies its technology to enhance the manufacturing of life-saving biopharmaceuticals.

Envisagenics, Inc. is a bioinformatics company founded in 2013 and headquartered in Huntington, New York. The company specializes in RNA therapeutics and aims to simplify complex biomedical data to expedite the development of innovative therapeutic solutions. Envisagenics leverages its advanced analytics platform, SpliceCore, which utilizes artificial intelligence and machine learning to analyze RNA sequencing data. This cloud-based platform enables researchers to identify splicing errors linked to various diseases, including genetic disorders and cancers, and to discover potential drug targets and biomarkers. By streamlining the drug discovery process through computational simulations, Envisagenics significantly reduces the time, cost, and risks associated with drug development, thereby facilitating partnerships with biopharmaceutical companies to advance RNA-based therapies.

FloDesign Sonics is a company that specializes in innovative acoustic technology aimed at transforming the separations and filtration sectors. The firm utilizes 3D non-linear acoustic standing waves to capture, separate, and purify mixtures without the need for physical membranes, chemicals, or centrifugation. This groundbreaking approach has broad applications across various industries, including life sciences, oil and gas, food and beverage, and industrial processing. The primary focus of FloDesign Sonics is in bioprocess separations, where it applies its technology to enhance the manufacturing of life-saving biopharmaceuticals.